Fundraising Fox
/People
Sign in

Dipal Doshi

Chief Executive Officer at Entrada Therapeutics, Inc.

New York, New York, United States

Find your path to Dipal

113 people in our graph share verified history with Dipal — schools, employers, funds. One of them is your warm intro.

Ted W. LoveunlockedDipal: together at Amicus Therapeutics (2014–2017)
×2Dipal: together at Catalent
×5Dipal: together at Publicis Sapient
×4Dipal: together at Eli Lilly

About

Dipal Doshi is Chief Executive Officer and a board member of Entrada Therapeutics (NASDAQ: TRDA), a clinical-stage biopharmaceutical company he joined as its first full-time employee in 2017. He has nearly 30 years of experience in the life sciences industry and previously served as Chief Business Officer at Amicus Therapeutics, along with senior roles at a healthcare private equity fund and Catalent. Doshi holds an MBA from The Wharton School of the University of Pennsylvania and a BA in English and Political Science from Rutgers University, and serves on the boards of the Biotechnology Innovation Organization, Azenta Life Sciences (NASDAQ: AZTA), and āshibio.

Chief Executive Officer at Entrada Therapeutics, Inc.

Intro paths

→

In turn, Dipal can intro founders to Entrada Therapeutics, Inc.'s investors below.

Entrada Therapeutics, Inc.'s investors · 6

5AM VenturesBoston · $100K – $4M checks · since 2021Agent CapitalWalthamMPM BioImpactBoston · $1M – $15M checks · since 2021MRL Ventures FundCambridge · $25M checksRoche Venture FundBasel · $648K – $3.2M checksTCG CrossoverPalo Alto

Experience

  1. Entrada TherapeuticsChief Executive Officer & Board Membercurrent2017 — presentBoston, Massachusetts, United States
  2. Biotechnology Innovation OrganizationMember, Board of Directorscurrent2026 — present
  3. Azenta Life SciencesMember, Board of Directorscurrent2025 — present
  4. āshibio, IncMember, Board of Directorscurrent2024 — present
  5. Amicus TherapeuticsChief Business Officer2014 — 2017Cranbury, New Jersey, United States
  6. Auven TherapeuticsSenior Vice President, Investments & Business Development2008 — 2013New York, New York, United States
  7. Catalent Pharma SolutionsHead, Corporate Development | Interim General Management Roles2005 — 2008Somerset, New Jersey, United States
  8. Merrill LynchAssociate, Investment Banking Group2004 — 2005New York, New York, United States
  9. Eli Lilly and CompanyHead, Oncology Healthcare Services for Lilly Ventures | Senior Associate, Oncology Marketing Group2001 — 2003Indianapolis, Indiana, United States
  10. Publicis SapientEngagement Manager, Strategy & Program Management Consulting Practices1998 — 2000Chicago, Illinois, United States
  11. Eli Lilly and CompanyPharmaceutical Sales Representative1997 — 1998New York, New York, United States

Skills & more

Executive LeadershipBoard of DirectorsBiotechnologyResearch and Development (R&D)Business DevelopmentBusiness StrategyHealthcareBiopharmaceuticalsBiotechnology IndustryPharmaceutical IndustryGeneral ManagementCorporate Leadership
+12 moreCorporate StrategyStrategic PartnershipsStrategic LeadershipInvestor RelationsOrganizational DevelopmentCorporate DevelopmentDrug DevelopmentClinical DevelopmentProduct DevelopmentRare DiseasesStrategic PlanningStrategy

From Dipal's professional profile.

Frequently asked questions

Who is Dipal Doshi?
Dipal Doshi is Chief Executive Officer and a board member of Entrada Therapeutics (NASDAQ: TRDA), a clinical-stage biopharmaceutical company he joined as its first full-time employee in 2017. He has nearly 30 years of experience in the life sciences industry and previously served as Chief Business Officer at Amicus Therapeutics, along with senior roles at a healthcare private equity fund and Catalent. Doshi holds an MBA from The Wharton School of the University of Pennsylvania and a BA in English and Political Science from Rutgers University, and serves on the boards of the Biotechnology Innovation Organization, Azenta Life Sciences (NASDAQ: AZTA), and āshibio.
Where does Dipal Doshi work?
Dipal Doshi is Chief Executive Officer at Entrada Therapeutics, Inc..
Where did Dipal Doshi go to school?
Dipal Doshi studied at The Wharton School (Master of Business Administration (MBA)); Rutgers University (Bachelor of Arts, English and Political Science).

Founder mafias

Same school

Shared employers